Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT01798771 Not yet recruiting - Glioblastoma Clinical Trials

Intraoperative MRI and 5-ALA Guidance to Improve the Extent of Resection in Brain Tumor Surgery

IMAGER
Start date: March 2013
Phase: N/A
Study type: Interventional

The investigators hypothesize that the rate of radiologically complete resections of contrast-enhancing brain tumors following surgeries aided by use of 5-ALA induced fluorescence guidance and use of an intraoperative ultra-low field MRI is higher compared to surgeries aided by 5-ALA induced fluorescene alone.

NCT ID: NCT01798537 Not yet recruiting - Bacteremia Clinical Trials

Simplified Selective Digestive Tract Decontamination for the Prevention of Intensive Care Unit Acquired Infections

SDDICU
Start date: June 2013
Phase: Phase 2/Phase 3
Study type: Interventional

A simplified graded gut decontamination protocol combined with rigorous bi-weekly screening and appropriate bacterial prophylaxis, will lead to a 25% reduction in the acquisition of blood stream infections and to a 25% reduction in lower airway colonization with multi drug resistant organisms. There will be no concomitant rise in gram-positive or fungal infection or a surgency of new resistance patterns.

NCT ID: NCT01791452 Not yet recruiting - Clinical trials for Non-alcoholic Fatty Liver Disease

Novel Association of Cholesterol Ester Storage Disease Due to Lysosomal Acid Lipase Deficiency and Non-Alcoholic Fatty Liver Disease: A Prospective Clinical Study

Start date: n/a
Phase: N/A
Study type: Observational

Non-alcoholic fatty liver disease (NAFLD) is a world-wide problem with a global prevalence estimated at 1.5 billion people. It is characterised by significant diversity and phenotypic heterogeneity. Morbidity rates are estimated at 20% to 30% in Western adults, increasing to 90% in patients who are morbidly obese or diabetic. Risk factors in non-obese NAFLD patients are of especial practical and theoretical importance. Cholesterol Ester Storage Disease (CESD) is an autosomal recessive chronic disease of variable phenotype, caused by a deficiency in lysosomal acid lipase (LAL) and characterized by accumulation of fat in tissues and organs. Hepatic accumulation of fat in this disorder can cause hepatomegaly with varying degrees of damage varying from steatosis to fibrosis, elevated aminotransaminases, and isolated splenomegaly. Since the contribution of LAL deficiency to non-obese NAFLD is poorly understood, the investigators propose to evaluating the association between NAFLD and LAL deficiency in a prospective study in our population.

NCT ID: NCT01790945 Not yet recruiting - Clinical trials for Diabetic Macular Edema

Diabetic Macular Edema and Diabetic Retinopathy Screening (TeleMed) With Automated Retinal Photography

DIVER
Start date: February 2013
Phase: N/A
Study type: Observational

The purpose of this study is explore if a partnership and screening program put in place between a busy retina practice and their referring diabetes care offices can improve diabetic retinopathy and diabetic macular edema diagnosis, care and overall diabetes control in patients with diabetic eye disease.

NCT ID: NCT01789450 Not yet recruiting - Clinical trials for Sensitivity of Nipple-areolar Complex

Nipple-Areola Complex Sensitivity After the Section of Periareolar Dermis in Breast Reduction

Start date: June 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the feasibility and sensitivity of nipple-areolar complex (NAC) prospectively due to the section of the dermis after decortication (Schwartzmann's maneuver), in 50 patients undergoing breast reduction surgery.

NCT ID: NCT01782521 Not yet recruiting - Clinical trials for Bonding Time Per Bracket

Is a Primer Needed for Orthodontic Bonding? A Multi-centre Trial

Start date: March 2013
Phase: N/A
Study type: Interventional

Orthodontic treatment is carried out by placing fixed attachments(brackets)on teeth with wires which run through them and create tooth movement. These metal brackets are bonded (glued) onto the tooth surface by a three step process. Firstly, a mild acid is used to roughen the tooth surface, secondly a free flowing glue (composite primer) is used to fill in the roughened pores and thirdly, the bracket is glued on to the tooth surface with a 'composite' material which sets hard by exposure to a high intensity light.The success of this procedure is measured by bracket failure rates. The literature review suggests that the scientific evidence is not clear to indicate whether the use of a primer is absolutely essential to achieve acceptable bracket success rates in a clinical environment. The primary aim of the study is to find out if the rate of loss of orthodontic brackets is clinically acceptable when they are glued onto the tooth surface without the use of a primer as compared to brackets bonded with a primer over a 12 month study period. The investigators will also investigate the Bonding time,Type of bracket bond failure,length of treatment and Peer Assessment Rating scores (PAR) This RCT will be undertaken on consented NHS patients in 3 hospitals in Yorkshire region by multiple operators The results from this study will help improve our knowledge of the best approach to bonding metal brackets on teeth. If the bracket failure rate is similar in both groups, this would indicate that the use of a primer is not always necessary. For patients, this would mean lesser time required to place brackets at the start of orthodontic treatment. For clinicians and NHS purchasers the outcome will influence cost effectiveness (as the primer is the most expensive component in the bonding process) and provide a framework for future studies.

NCT ID: NCT01781221 Not yet recruiting - Clinical trials for Posterior Maxilla Edentulous Patients With Insufficient Alveolar Bone Height

Sinus Floor Elevation Using Separately Two Different Xenografts - A Prospective Randomized Clinical Trial

Start date: February 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the regenerative results of using separately two different xenografts after two-step sinus floor elevation.

NCT ID: NCT01779531 Not yet recruiting - Clinical trials for Human Epidermal Growth Factor 2 Negative Carcinoma of Breast

Compare the Outcomes of XT and XEC Adjuvant Chemotherapy in HER2-negative Luminal B Breast Cancer Patients

Start date: January 2013
Phase: N/A
Study type: Observational

Human epidermalgrowth factor receptor-2(HER2) negative Luminal B subtype breast cancer patients are included. After 4 cycles of Capecitabine combined with Docetaxel(XT) protocol neoadjuvant chemotherapy ,those who reach partial response(PR) but not pathological complete response(pCR) are randomly divided into the group treated with XT protocol and the group with Capecitabine combined with Epirubicin and Cyclophosphamide(XEC) protocol ,then compare the disease free survival(DFS) and overall survival(OS) of two subgroup.

NCT ID: NCT01772927 Not yet recruiting - Failure to Thrive Clinical Trials

Clinical Tolerance of Numeta 13%

BAXTERULG2
Start date: January 2013
Phase: N/A
Study type: Observational

Numeta G13% is a triple chamber bag including amino acids plus electrolytes, glucose and lipids, dedicated for parenteral nutrition in preterm newborn infants when oral/enteral nutrition is not possible, insufficient or contra indicated. The product has been registered in 18 countries in Europe via a decentralized procedure that ended 15th December 2010. The present study want to evaluate the use of Numeta 13% as standard medical prescription in the NICU of the university of Liege. It is a prospective, monocentric, non-interventional, non comparative, open-labeled data collection of record keeping, nutritional intakes from the bags, additional intakes as well as blood and urine biochemical markers currently evaluated in the NICU. The data will be collected only in VLBWI < 1500 g receiving Numeta G13% from day of birth (day 1) until parenteral nutrition (PN) decreases below 20% of the targeted intakes 2 days in a row as a quality control of the new solution in clinical practice. Indication for PN and daily prescription will follow the protocol in use in the NICU on behalf of the investigators

NCT ID: NCT01768364 Not yet recruiting - Clinical trials for Ureteric Stent After Stone Surgery

Antibiotic Prophylaxis When Removing Ureteric Stent After Stone Surgery

Start date: January 2013
Phase: N/A
Study type: Interventional

Is there anything to gain in giving antibiotics as prophylaxis when removing ureteric stents cystoscopically after stone surgery?